These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31723415)

  • 1. Podocyte RhoGTPases: new therapeutic targets for nephrotic syndrome?
    Saleem MA; Welsh GI
    F1000Res; 2019; 8():. PubMed ID: 31723415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte Geranylgeranyl Transferase Type-I Is Essential for Maintenance of the Glomerular Filtration Barrier.
    Boi R; Bergwall L; Ebefors K; Bergö MO; Nyström J; Buvall L
    J Am Soc Nephrol; 2023 Apr; 34(4):641-655. PubMed ID: 36735952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte-specific loss of Cdc42 leads to congenital nephropathy.
    Scott RP; Hawley SP; Ruston J; Du J; Brakebusch C; Jones N; Pawson T
    J Am Soc Nephrol; 2012 Jul; 23(7):1149-54. PubMed ID: 22518006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance.
    Rogg M; Maier JI; Dotzauer R; Artelt N; Kretz O; Helmstädter M; Abed A; Sammarco A; Sigle A; Sellung D; Dinse P; Reiche K; Yasuda-Yamahara M; Biniossek ML; Walz G; Werner M; Endlich N; Schilling O; Huber TB; Schell C
    J Am Soc Nephrol; 2021 Mar; 32(3):563-579. PubMed ID: 33514561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance.
    Tian X; Kim JJ; Monkley SM; Gotoh N; Nandez R; Soda K; Inoue K; Balkin DM; Hassan H; Son SH; Lee Y; Moeckel G; Calderwood DA; Holzman LB; Critchley DR; Zent R; Reiser J; Ishibe S
    J Clin Invest; 2014 Mar; 124(3):1098-113. PubMed ID: 24531545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Rho GTPase Interacting Proteins in Subcellular Compartments of Podocytes.
    Asano-Matsuda K; Ibrahim S; Takano T; Matsuda J
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the podocyte cytoskeleton: from pathogenesis to therapy in proteinuric kidney disease.
    Tian X; Ishibe S
    Nephrol Dial Transplant; 2016 Oct; 31(10):1577-83. PubMed ID: 26968197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of Rho GTPase Activity in Podocytes.
    Matsuda J; Takano T
    Methods Mol Biol; 2023; 2664():343-349. PubMed ID: 37423999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome.
    Oh J; Reiser J; Mundel P
    Pediatr Nephrol; 2004 Feb; 19(2):130-7. PubMed ID: 14673634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of podocytes in glomerular pathobiology.
    Asanuma K; Mundel P
    Clin Exp Nephrol; 2003 Dec; 7(4):255-9. PubMed ID: 14712353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes.
    Yanagida-Asanuma E; Asanuma K; Kim K; Donnelly M; Young Choi H; Hyung Chang J; Suetsugu S; Tomino Y; Takenawa T; Faul C; Mundel P
    Am J Pathol; 2007 Aug; 171(2):415-27. PubMed ID: 17569780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NF-κB essential modulator (NEMO) controls podocyte cytoskeletal dynamics independently of NF-κB.
    Brähler S; Ising C; Barrera Aranda B; Höhne M; Schermer B; Benzing T; Brinkkoetter PT
    Am J Physiol Renal Physiol; 2015 Oct; 309(7):F617-26. PubMed ID: 26268269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of nephrotic syndrome: new insights into molecules acting at the glomerular filtration barrier.
    Zenker M; Machuca E; Antignac C
    J Mol Med (Berl); 2009 Sep; 87(9):849-57. PubMed ID: 19649571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin controls cytoskeleton reorganization and filtration barrier permeability via the PKGIα-Rac1-RhoA crosstalk in cultured rat podocytes.
    Rachubik P; Szrejder M; Rogacka D; Typiak M; Audzeyenka I; Kasztan M; Pollock DM; Angielski S; Piwkowska A
    Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119301. PubMed ID: 35642843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Podocyte Biology.
    Garg P
    Am J Nephrol; 2018; 47 Suppl 1():3-13. PubMed ID: 29852492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies.
    Ye Q; Lan B; Liu H; Persson PB; Lai EY; Mao J
    Acta Physiol (Oxf); 2022 Aug; 235(4):e13850. PubMed ID: 35716094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?
    Müller-Deile J; Schiffer M
    Pediatr Nephrol; 2016 Mar; 31(3):393-405. PubMed ID: 25939817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury.
    Blattner SM; Hodgin JB; Nishio M; Wylie SA; Saha J; Soofi AA; Vining C; Randolph A; Herbach N; Wanke R; Atkins KB; Gyung Kang H; Henger A; Brakebusch C; Holzman LB; Kretzler M
    Kidney Int; 2013 Nov; 84(5):920-30. PubMed ID: 23677246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of rituximab on puromycin-induced apoptosis, loss of adhesion and cytoskeletal alterations in human podocytes.
    Jeruschke S; Alex D; Hoyer PF; Weber S
    Sci Rep; 2022 Jul; 12(1):12297. PubMed ID: 35853959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
    Sever S; Schiffer M
    Kidney Int; 2018 Jun; 93(6):1298-1307. PubMed ID: 29678354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.